Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2020 2020-06-02
VOLUNTARY ANNOUNCEMENT - COLLABORATION AGREEMENT OF ANTI-TUMOR COMBINATION THERAPY WITH SLP 2020-05-28
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON MAY 25, 2020 2020-05-25
Next Day Disclosure Return 2020-05-21
VOLUNTARY ANNOUNCEMENT - ABSTRACTS ON USING TRANSLATIONAL TGI MODEL AND POPULATION PK ANALYSIS FOR KN026 ACCEPTED FOR POSTER PRESENTATION AT 2020 AACR ANNUAL MEETING 2020-05-18
ABSTRACTS ON PRELIMINARY RESULTS FROM CLINICAL TRIALS OF KN035 ACCEPTED FOR POSTER PRESENTATION AT 2020 ASCO ANNUAL MEETING 2020-05-15
VOLUNTARY ANNOUNCEMENT - ABSTRACTS ON PRELIMINARY RESULTS FROM CLINICAL TRIALS OF KN026 AND KN046 ACCEPTED FOR POSTER PRESENTATION AT 2020 ASCO ANNUAL MEETING 2020-05-14
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2020 2020-05-06
2019 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2020-04-22
NOTICE OF ANNUAL GENERAL MEETING 2020-04-21

23 24 25 26 27 28 29